ROST
66
-4
V
48
-4
CMA
59
-2
ALLE
46
-4
DOV
63
-6
ITW
33
-6
HRL
23
-9
KMX
36
-4
LB
22
-5
HCA
59
-3
HSY
45
10
WFC
68
-4
MOS
29
-3
GRMN
34
-6
PSA
48
10
ETR
47
-7
IP
34
-5
ZBH
45
-2
O
33
-4
GM
77
-3
ROST
66
-4
V
48
-4
CMA
59
-2
ALLE
46
-4
DOV
63
-6
ITW
33
-6
HRL
23
-9
KMX
36
-4
LB
22
-5
HCA
59
-3
HSY
45
10
WFC
68
-4
MOS
29
-3
GRMN
34
-6
PSA
48
10
ETR
47
-7
IP
34
-5
ZBH
45
-2
O
33
-4
GM
77
-3
Financhill
Back

BioXcel Therapeutics, Inc. Vs. Vertex Pharmaceuticals, Inc. Industry Stock Comparison

Sell
23

BTAI
BioXcel Therapeutics, Inc.

Last Price:
$1.65
Seasonality Move:
59.54%
Sell
48

VRTX
Vertex Pharmaceuticals, Inc.

Last Price:
$452.13
Seasonality Move:
0.02%
Sell
23
BioXcel Therapeutics, Inc. (BTAI) is a Sell

Is BioXcel Therapeutics, Inc. a Buy, Sell or Hold?

  • The current BioXcel Therapeutics, Inc. [BTAI] share price is $1.60. The Score for BTAI is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • BTAI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Vertex Pharmaceuticals, Inc. (VRTX) is a Sell

Is Vertex Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Vertex Pharmaceuticals, Inc. [VRTX] share price is $453.36. The Score for VRTX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • VRTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BTAI Stock Price Chart

What is BioXcel Therapeutics, Inc.'s stock price today?

  • The BioXcel Therapeutics, Inc. share price today is $1.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BTAI is experiencing buying pressure, which is a positive indicator for future bullish movement.

VRTX Stock Price Chart

What is Vertex Pharmaceuticals, Inc.'s stock price today?

  • The Vertex Pharmaceuticals, Inc. share price today is $453.36
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRTX is experiencing slight selling pressure.

BTAI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.12 Sell
Relative Strength Index (14 RSI): 37.18 Sell
Chaikin Money Flow: 540689 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.71 - 2.11) Sell
Bollinger Bands (100): (1.59 - 3.97) Sell

VRTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 125.77 Buy
Relative Strength Index (14 RSI): 54.61 Buy
Chaikin Money Flow: -157875 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (437.91 - 460.33) Buy
Bollinger Bands (100): (392.1 - 440.74) Buy

BTAI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.67 Sell
20-day SMA: 1.87 Sell
50-day SMA: 1.94 Sell
200-day SMA: 2.3 Sell
8-day EMA: 1.67 Sell
20-day EMA: 1.8 Sell
50-day EMA: 2.02 Sell
200-day EMA: 4.36 Sell

VRTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 458.56 Sell
20-day SMA: 453.68 Sell
50-day SMA: 436.81 Buy
200-day SMA: 439.72 Buy
8-day EMA: 419.89 Buy
20-day EMA: 288.97 Buy
50-day EMA: 150.59 Buy
200-day EMA: 43.45 Buy

BioXcel Therapeutics, Inc. Earnings Growth & BTAI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.68 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.74 per share, and an increase next year of $0.96 per share.

Vertex Pharmaceuticals, Inc. Earnings Growth & VRTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.79 per share, and an increase next year of $2.27 per share.

BioXcel Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Vertex Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):